Filing Details
- Accession Number:
- 0000899243-20-035011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-23 17:35:45
- Reporting Period:
- 2020-12-21
- Accepted Time:
- 2020-12-23 17:35:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1743881 | Bridgebio Pharma Inc. | BBIO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1214133 | H Richard Scheller | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-21 | 14,928 | $64.81 | 91,333 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-21 | 45,473 | $65.48 | 45,860 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the weighted average sale price of the shares sold from $64.15 to $65.13 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 1 and 2.
- Represents the weighted average sale price of the shares sold from $65.15 to $65.76 per share.